Phio Pharmaceuticals Corp. (PHIO) Operating cash flow 2016–2025
Phio Pharmaceuticals Corp. (PHIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.0MFY2025 · since FY2016: -$7.8M → -$8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.0M | -12.2% |
| FY2024 | -$7.1M | +33.8% |
| FY2023 | -$10.7M | +11.4% |
| FY2022 | -$12.1M | -2.3% |
| FY2021 | -$11.9M | -34.7% |
| FY2020 | -$8.8M | -1.8% |
| FY2019 | -$8.6M | -15.0% |
| FY2018 | -$7.5M | +21.0% |
| FY2017 | -$9.5M | -22.6% |
| FY2016 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PHIO financial trends
PHIO RevenuePHIO Net incomePHIO Net marginPHIO Gross profitPHIO Gross marginPHIO Operating incomePHIO Operating marginPHIO Free cash flowPHIO Capital expendituresPHIO Return on equityPHIO Stock buybacksPHIO Dividends paidPHIO Total assetsPHIO Total liabilitiesPHIO Shareholders’ equityPHIO overview →